Efficacy of Human albumin in prevention of hypotension during hemodialysis in critically ill patients with low albumi
Phase 3
- Conditions
- Health Condition 1: N17- Acute kidney failureHealth Condition 2: N18- Chronic kidney disease (CKD)
- Registration Number
- CTRI/2023/07/055384
- Lead Sponsor
- Dr Rakesh kumar Mohapatra and Dr Debananda Sahoo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Adult critically ill patients with AKI or Acute on CKD requiring Hemodialysis
And
2. Patients with serum Albumin less than 2.5 gm/dl
Exclusion Criteria
1. Refusal for consent to participate in the study
2. Patients with other clinical condition(s) requiring albumin as therapy:
a. Spontaneous bacterial peritonitis
b. Large volume paracentesis
c. Hepatorenal syndrome
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the efficacy of human albumin in preventing Intradialytic hypotension in critically ill patients with hypoalbuminemia undergoing haemodialysis. <br/ ><br>Timepoint: 4 hours <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.To compare the fluid removal in ml/kg/hour. <br/ ><br>2.To compare the vasopressor requirementTimepoint: 4 hours